Muhammad Asif
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Asif has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Fakhar-E-Alam Kulyar
Institute of Clinical Immunology and Allergology, First Faculty of Medicine, Charles University, Prague, Czech Republic
3 shared publications - Zeeshan Ahmad Bhutta
Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea
3 shared publications - Moazam Ali
Department of Clinical Medicine and Surgery, University of Agriculture, Faisalabad, Pakistan
2 shared publications - Shah Nawaz
College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
2 shared publications - Ambreen Ashar
Department of Chemistry, University of Agriculture, Faisalabad, Pakistan
1 shared publication Ashar Mahfooz
University of Agriculture Faisalabad, Department of Clinical Medicine and Surgery, University of Agriculture Faisalabad, 38000, Pakistan, Faisalabad, 38000, PAKISTAN
1 shared publication
Latest Publications
- 8 September 2021
- Published by IOP Publishing in Nanotechnology
- Vol. 32 (48) , 482001
Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic
The COVID-19 outbreak is creating severe impressions on all facets of the global community. Despite strong measures worldwide to try and re-achieve normalcy, the ability of SARS-CoV-2 to survive sturdy ecological settings may contribute to its rapid spread. Scientists from different aspects of life are working together to develop effective treatment strategies against SARS-CoV-2. Apart from using clinical devices for patient recovery, the key focus is on developing antiviral drugs and vaccines. Given the physical size of the SARS-CoV-2 pathogen and with the vaccine delivery platform currently undergoing clinical trials, the link between nanotechnology is clear, and previous antiviral research using nanomaterials confirms this link. Nanotechnology based products can effectively suppress various pathogens, including viruses, regardless of drug resistance, biological structure, or physiology. Thus, nanotechnology is opening up new dimensions for developing new strategies for diagnosing, preventing, treating COVID-19 and other viral ailments. This article describes the application of nanotechnology against the COVID-19 virus in terms of therapeutic purposes and vaccine development through the invention of nanomaterial based substances such as sanitizers (handwashing agents and surface disinfectants), masks and gowns, amongst other personal protective equipment, diagnostic tools, and nanocarrier systems, as well as the drawbacks and challenges of nanotechnology that need to be addressed.
- 8 September 2021
- Published by IOP Publishing in Nanotechnology
- Vol. 32 (48) , 482001
Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic
The COVID-19 outbreak is creating severe impressions on all facets of the global community. Despite strong measures worldwide to try and re-achieve normalcy, the ability of SARS-CoV-2 to survive sturdy ecological settings may contribute to its rapid spread. Scientists from different aspects of life are working together to develop effective treatment strategies against SARS-CoV-2. Apart from using clinical devices for patient recovery, the key focus is on developing antiviral drugs and vaccines. Given the physical size of the SARS-CoV-2 pathogen and with the vaccine delivery platform currently undergoing clinical trials, the link between nanotechnology is clear, and previous antiviral research using nanomaterials confirms this link. Nanotechnology based products can effectively suppress various pathogens, including viruses, regardless of drug resistance, biological structure, or physiology. Thus, nanotechnology is opening up new dimensions for developing new strategies for diagnosing, preventing, treating COVID-19 and other viral ailments. This article describes the application of nanotechnology against the COVID-19 virus in terms of therapeutic purposes and vaccine development through the invention of nanomaterial based substances such as sanitizers (handwashing agents and surface disinfectants), masks and gowns, amongst other personal protective equipment, diagnostic tools, and nanocarrier systems, as well as the drawbacks and challenges of nanotechnology that need to be addressed.
- 26 January 2021
- Published by Springer Nature in BioNanoScience
- Vol. 11 (2) , 621-632
Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO2NPs) and Their Jeopardy to Human Population
Titanium dioxide nanoparticles (TiO2 NPs) are the most produced nanomaterial for food additives, pigments, photocatalysis, and personal care products. These nanomaterials are at the forefront of rapidly developing indispensable nanotechnology. In all these nanomaterials, titanium dioxide (TiO2) is the most common nanomaterial which is being synthesized for many years. These nanoparticles of TiO2 are widely used at the commercial level, especially in cosmetic industries. High usage in such a way has increased the toxicological consequences of the human population. Several studies have shown that TiO2 NPs accumulated after oral exposure or inhalation in the alimentary canal, lungs, heart, liver, spleen, cardiac muscle, and kidneys. Additionally, in mice and rats, they disturb glucose and lipid homeostasis. Moreover, TiO2 nanoparticles primarily cause adverse reactions by inducing oxidative stress that leads to cell damage, inflammation, genotoxicity, and adverse immune responses. The form and level of destruction are strongly based on the physical and chemical properties of TiO2 nanoparticles, which administer their reactivity and bioavailability. Studies give indications that TiO2 NPs cause both DNA strand breaks and chromosomal damages. The effects of genotoxicity do not depend only on particle surface changes, size, and exposure route, but also relies on the duration of exposure. Most of these effects may be because of a very high dose of TiO2 NPs. Despite increased production and use, epidemiological data for TiO2 NPs is still missing. This review discusses previous research regarding the impact of TiO2 NP toxicity on human health and highlights areas that require further understanding in concern of jeopardy to the human population. This review is important to point out areas where extensive research is needed; thus, their possible impact on individual health should be investigated in more details.
- 26 January 2021
- Published by Springer Nature in BioNanoScience
- Vol. 11 (2) , 621-632
Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO2NPs) and Their Jeopardy to Human Population
Titanium dioxide nanoparticles (TiO2 NPs) are the most produced nanomaterial for food additives, pigments, photocatalysis, and personal care products. These nanomaterials are at the forefront of rapidly developing indispensable nanotechnology. In all these nanomaterials, titanium dioxide (TiO2) is the most common nanomaterial which is being synthesized for many years. These nanoparticles of TiO2 are widely used at the commercial level, especially in cosmetic industries. High usage in such a way has increased the toxicological consequences of the human population. Several studies have shown that TiO2 NPs accumulated after oral exposure or inhalation in the alimentary canal, lungs, heart, liver, spleen, cardiac muscle, and kidneys. Additionally, in mice and rats, they disturb glucose and lipid homeostasis. Moreover, TiO2 nanoparticles primarily cause adverse reactions by inducing oxidative stress that leads to cell damage, inflammation, genotoxicity, and adverse immune responses. The form and level of destruction are strongly based on the physical and chemical properties of TiO2 nanoparticles, which administer their reactivity and bioavailability. Studies give indications that TiO2 NPs cause both DNA strand breaks and chromosomal damages. The effects of genotoxicity do not depend only on particle surface changes, size, and exposure route, but also relies on the duration of exposure. Most of these effects may be because of a very high dose of TiO2 NPs. Despite increased production and use, epidemiological data for TiO2 NPs is still missing. This review discusses previous research regarding the impact of TiO2 NP toxicity on human health and highlights areas that require further understanding in concern of jeopardy to the human population. This review is important to point out areas where extensive research is needed; thus, their possible impact on individual health should be investigated in more details.
- Open Access
- 24 June 2020
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 8 (6) , 1283-1285
Conventional Medicine in the Treatment of Different Diseases as a Complementary and Alternative Medicine
Traditional medicine is still the only treatment in many rural areas especially the rural communities of east. Due to limited access to modern medicine, local people use medicinal plants to treat most diseases. Some herbs contain powerful contents and must be treated with the same precautionary care as in the case of drug, we do. In fact, a lot of drugs are basically based on artificial verities of natural composite in plants. For example, the heart drug Digitalis comes from a foxglove plant. Some drugs are single active substance derived from botanical sources. Herbalists believe that if the active ingredient is isolated from other parts of the plant, its action may be lost or its safety may be reduced. E.g, salicylic acid is present in a plant of meadowsweet which is used for aspirin production. Aspirin may cause bleeding in the gastric mucosa, but meadowsweet contains some other compounds naturally that interfere with the stimulation of salicylic acid. According to some practitioners, the effect of whole plant is greater than its parts individually. Critics believe that the nature of the herbs makes itself difficult to administer of such active ingredients. Herbs contain active ingredients, Mostly of them have unknown ingredients. As with other prescription drugs, herbs should always be prescribed by a qualified doctor.
- 24 June 2020
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 8 (6) , 1283-1285
Open AccessConventional Medicine in the Treatment of Different Diseases as a Complementary and Alternative Medicine
Traditional medicine is still the only treatment in many rural areas especially the rural communities of east. Due to limited access to modern medicine, local people use medicinal plants to treat most diseases. Some herbs contain powerful contents and must be treated with the same precautionary care as in the case of drug, we do. In fact, a lot of drugs are basically based on artificial verities of natural composite in plants. For example, the heart drug Digitalis comes from a foxglove plant. Some drugs are single active substance derived from botanical sources. Herbalists believe that if the active ingredient is isolated from other parts of the plant, its action may be lost or its safety may be reduced. E.g, salicylic acid is present in a plant of meadowsweet which is used for aspirin production. Aspirin may cause bleeding in the gastric mucosa, but meadowsweet contains some other compounds naturally that interfere with the stimulation of salicylic acid. According to some practitioners, the effect of whole plant is greater than its parts individually. Critics believe that the nature of the herbs makes itself difficult to administer of such active ingredients. Herbs contain active ingredients, Mostly of them have unknown ingredients. As with other prescription drugs, herbs should always be prescribed by a qualified doctor.